AIG
NVET

American International Group’s Nexvet Biopharma plc Ordinary Shares NVET Stock Holding History

American International Group’s Portfolio NVET Stock Details NVET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-90
Closed – – 4897
2016
Q1 		$0 Hold
90
– – ﹤0.01% 5196
2015
Q4 		$0 Hold
90
– – ﹤0.01% 5153
2015
Q3 		$0 Hold
90
– – ﹤0.01% 5136
2015
Q2 		$447 Buy
+90
New +$624 ﹤0.01% 5035

Other funds holding NVET

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
LLC
Latimer Light Capital New York $432M AUM 25.5% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
CI
Cowen Inc New York $1.39B AUM 60.14% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

American International Group's NVET Position: Q2 2016 in Review

American International Group sold out of Nexvet Biopharma plc Ordinary Shares (NVET) in Q2 2016, closing a stake of 90 shares.

American International Group first reported a position in NVET in Q2 2015 and held it in 4 quarters. The position peaked at $447 in Q2 2015. 15 funds tracked by Wall St. Rank hold NVET as of Q2 2016.

  • American International Group reported no remaining Nexvet Biopharma plc Ordinary Shares position as of Q2 2016 after selling out during the quarter.
  • American International Group sold 90 Nexvet Biopharma plc Ordinary Shares shares in Q2 2016.
  • American International Group first reported a position in Nexvet Biopharma plc Ordinary Shares in Q2 2015 and held it in 4 quarters.
  • American International Group's Nexvet Biopharma plc Ordinary Shares position peaked at $447 in Q2 2015.
  • 15 funds tracked by Wall St. Rank held Nexvet Biopharma plc Ordinary Shares as of Q2 2016.

Based on American International Group's 13F filing for Q2 2016, filed 11 Aug 2016.